Cp/Heph mutant mice have iron-induced neurodegeneration diminished by deferiprone.

被引:33
作者
Zhao, Liangliang [1 ,2 ]
Hadziahmetovic, Majda [1 ,3 ]
Wang, Chenguang [1 ,2 ]
Xu, Xueying [4 ]
Song, Ying [1 ]
Jinnah, H. A. [5 ]
Wodzinska, Jolanta [6 ]
Iacovelli, Jared [1 ]
Wolkow, Natalie [1 ]
Krajacic, Predrag [1 ]
Weissberger, Alyssa Cwanger [1 ]
Connelly, John [6 ]
Spino, Michael [6 ,7 ]
Lee, Michael K. [8 ]
Connor, James [9 ]
Giasson, Benoit [10 ]
Harris, Z. Leah [11 ]
Dunaief, Joshua L. [1 ]
机构
[1] Univ Penn, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA
[2] Jilin Univ, Hosp 2, Dept Ophthalmol, Changchun, Jilin, Peoples R China
[3] Drexel Univ, Coll Med, Dept Ophthalmol, Philadelphia, PA 19104 USA
[4] Sinai Hosp, Dept Med, Baltimore, MD 21215 USA
[5] Emory Univ, Sch Med, Dept Neurol Human Genet & Pediat, Atlanta, GA USA
[6] ApoPharma Inc, Toronto, CA USA
[7] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5S 3M2, Canada
[8] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA
[9] Penn State Milton S Hershey Med Ctr, Dept Neurosurg, Hershey, PA USA
[10] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA
[11] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Chicago, IL 60611 USA
基金
美国国家卫生研究院;
关键词
ceruloplasmin/Hephaestin; deferiprone; glia; iron; neurodegeneration; oxidative stress; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; LEWY BODY DISEASE; PARKINSONS-DISEASE; OXIDATIVE STRESS; CELL-DEATH; MICROGLIAL ACTIVATION; MACULAR DEGENERATION; CERULOPLASMIN GENE; FRIEDREICH ATAXIA;
D O I
10.1111/jnc.13292
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Brain iron accumulates in several neurodegenerative diseases and can cause oxidative damage, but mechanisms of brain iron homeostasis are incompletely understood. Patients with mutations in the cellular iron-exporting ferroxidase ceruloplasmin (Cp) have brain iron accumulation causing neurodegeneration. Here, we assessed the brains of mice with combined mutation of Cp and its homolog hephaestin. Compared to single mutants, brain iron accumulation was accelerated in double mutants in the cerebellum, substantia nigra, and hippocampus. Iron accumulated within glia, while neurons were iron deficient. There was loss of both neurons and glia. Mice developed ataxia and tremor, and most died by 9 months. Treatment with the oral iron chelator deferiprone diminished brain iron levels, protected against neuron loss, and extended lifespan. Ferroxidases play important, partially overlapping roles in brain iron homeostasis by facilitating iron export from glia, making iron available to neurons.
引用
收藏
页码:958 / 974
页数:17
相关论文
共 50 条
[1]  
Alam ZI, 1997, J NEUROCHEM, V69, P1326
[2]   The expression and regulation of the iron transport molecules hephaestin and IREG1 - Implications for the control of iron export from the small intestine [J].
Anderson, GJ ;
Frazer, DM ;
McKie, AT ;
Wilkins, SJ ;
Vulpe, CD .
CELL BIOCHEMISTRY AND BIOPHYSICS, 2002, 36 (2-3) :137-146
[3]   Parkinson's Disease Iron Deposition Caused by Nitric Oxide-Induced Loss of β-Amyloid Precursor Protein [J].
Ayton, Scott ;
Lei, Peng ;
Hare, Dominic J. ;
Duce, James A. ;
George, Jessica L. ;
Adlard, Paul A. ;
McLean, Catriona ;
Rogers, Jack T. ;
Cherny, Robert A. ;
Finkelstein, David I. ;
Bush, Ashley I. .
JOURNAL OF NEUROSCIENCE, 2015, 35 (08) :3591-3597
[4]   Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: implications for Parkinson's disease [J].
Ayton, Scott ;
Lei, Peng ;
Adlard, Paul A. ;
Volitakis, Irene ;
Cherny, Robert A. ;
Bush, Ashley I. ;
Finkelstein, David I. .
MOLECULAR NEURODEGENERATION, 2014, 9
[5]   Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease [J].
Ayton, Scott ;
Lei, Peng ;
Duce, James A. ;
Wong, Bruce X. W. ;
Sedjahtera, Amelia ;
Adlard, Paul A. ;
Bush, Ashley I. ;
Finkelstein, David I. .
ANNALS OF NEUROLOGY, 2013, 73 (04) :554-559
[6]   Selective iron chelation in Friedreich ataxia:: biologic and clinical implications [J].
Boddaert, Nathalie ;
Sang, Kim Hanh Le Quart ;
Roetig, Agnes ;
Leroy-Willig, Anne ;
Gallet, Serge ;
Brunelle, Francis ;
Sidi, Daniel ;
Thalabard, Jean-Christophe ;
Munnich, Arnold ;
Cabantchik, Z. Ioav .
BLOOD, 2007, 110 (01) :401-408
[7]   Identification of Zyklopen, a New Member of the Vertebrate Multicopper Ferroxidase Family, and Characterization in Rodents and Human Cells [J].
Chen, Huijun ;
Attieh, Zouhair K. ;
Syed, Basharut A. ;
Kuo, Yien-Ming ;
Stevens, Valerie ;
Fuqua, Brie K. ;
Andersen, Henriette S. ;
Naylor, Claire E. ;
Evans, Robert W. ;
Gambling, Lorraine ;
Danzeisen, Ruth ;
Bacouri-Haidar, Mhenia ;
Usta, Julnar ;
Vulpe, Chris D. ;
McArdle, Harry J. .
JOURNAL OF NUTRITION, 2010, 140 (10) :1728-1735
[8]   Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): Results from a four years follow-up [J].
Cossu, Giovanni ;
Abbruzzese, Giovanni ;
Matta, Gildo ;
Murgia, Daniela ;
Melis, Maurizio ;
Ricchi, Valeria ;
Galanello, Renzo ;
Barella, Susanna ;
Origa, Raffaella ;
Balocco, Manuela ;
Pelosin, Elisa ;
Marchese, Roberta ;
Ruffinengo, Uberto ;
Forni, Gian Luca .
PARKINSONISM & RELATED DISORDERS, 2014, 20 (06) :651-654
[9]   Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin [J].
De Domenico, Ivana ;
Ward, Diane McVey ;
Di Patti, Maria Carmela Bonaccorsi ;
Jeong, Suh Young ;
David, Samuel ;
Musci, Giovanni ;
Kaplan, Jerry .
EMBO JOURNAL, 2007, 26 (12) :2823-2831
[10]   Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapy [J].
Devanur, Lakshmi D. ;
Evans, Robert W. ;
Evans, Patricia J. ;
Hider, Robert C. .
BIOCHEMICAL JOURNAL, 2008, 409 (02) :439-447